A review of the New Zealand National Joint Registry to compare the outcomes of Coonrad-Morrey and Latitude total elbow arthroplasty

Viswanath, Aparna; Frampton, Chris; Poon, Peter C.

doi:10.1016/j.jse.2019.12.021

Cited by 19 publications

(20 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is congruent with other registry studies, reporting rheumatoid arthritis as the most common indication. 1,24,25 Globally, the indications for TEA are shifting from rheumatoid arthritis and primary arthritis to trauma-related indications. 1 The trend toward traumatic indications for TEA is supported by a study by McKee et al, 27 which, to date, has been cited 439 times.…”

Section: Discussionmentioning

confidence: 99%

“…22,23 To our knowledge, only five studies have been published using registry data to analyze and compare the outcomes of TEA. 7,12,13,24,25 Therefore, the primary aim of this study is to report the implant survival of TEA, using data from the Dutch arthroplasty registry (Landelijke Registratie Orthopedische Implantaten (LROI)). The secondary aim is to identify factors associated with revision.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Implant survival of total elbow arthroplasty: analysis of 514 cases from the Dutch Arthroplasty Registry

et al. 2023

View full text Add to dashboard Cite

AimsThe aim of this study is to report the implant survival and factors associated with revision of total elbow arthroplasty (TEA) using data from the Dutch national registry.MethodsAll TEAs recorded in the Dutch national registry between 2014 and 2020 were included. The Kaplan-Meier method was used for survival analysis, and a logistic regression model was used to assess the factors associated with revision.ResultsA total of 514 TEAs were included, of which 35 were revised. The five-year implant survival was 91%. Male sex, a higher BMI, and previous surgery to the same elbow showed a statistically significant association with revision (p < 0.036). Of the 35 revised implants, ten (29%) underwent a second revision.ConclusionThis study reports a five-year implant survival of TEA of 91%. Patient factors associated with revision are defined and can be used to optimize informed consent and shared decision-making. There was a high rate of secondary revisions.Cite this article: Bone Jt Open 2023;4(2):110–119.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Implant survival of total elbow arthroplasty: analysis of 514 cases from the Dutch Arthroplasty Registry

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Similar results have been reported for linked and unlinked Latitude prostheses. 5,17,29,31 It is considered an advantage of the Latitude prosthesis that it offers the possibility to decide whether the prosthesis is placed in a linked or unlinked manner. Yet, considering the lack of clear evidence for use of one design over the other, it is difficult to make an evidence-based decision.…”

Section: Discussionmentioning

confidence: 99%

Mid-term results of the Latitude primary total elbow arthroplasty

Meijering

Boerboom

Gerritsma

et al. 2022

Journal of Shoulder and Elbow Surgery

View full text Add to dashboard Cite

“…Against this, many strategies, including new types of prosthesis, wear-resistant materials, surgical methods, fixation techniques, and rehabilitation management improvements, have been developed and applied in TJA [17][18][19][20][21]. These strategies greatly avoid joint prosthesis loosening and wear, but wear still cannot be solved completely.…”

Section: Discussionmentioning

confidence: 99%

“…Joint prosthesis longevity and function are largely dependent on the degree of interface wear between the bone and implant, as well as the formation pace of wear particles. Against this, many strategies, including new types of prosthesis, wear-resistant materials, surgical methods, fixation techniques, and rehabilitation management improvements, have been developed and applied in TJA [ 17 – 21 ]. These strategies greatly avoid joint prosthesis loosening and wear, but wear still cannot be solved completely.…”

Section: Discussionmentioning

confidence: 99%

Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation

Zhu

Wang

et al. 2021

Journal of Immunology Research

View full text Add to dashboard Cite

Wear particle-induced periprosthetic osteolysis is mainly responsible for joint replacement failure and revision surgery. Curculigoside is reported to have bone-protective potential, but whether curculigoside attenuates wear particle-induced osteolysis remains unclear. In this study, titanium particles (Ti) were used to stimulate osteoblastic MC3T3-E1 cells in the presence or absence of curculigoside, to determine their effect on osteoblast differentiation. Rat osteoclastic bone marrow stromal cells (BMSCs) were cocultured with Ti in the presence or absence of curculigoside, to evaluate its effect on osteoclast formation in vitro. Ti was also used to stimulate mouse calvaria to induce an osteolysis model, and curculigoside was administrated to evaluate its effect in the osteolysis model by micro-CT imaging and histopathological analyses. As the results indicated, in MC3T3-E1 cells, curculigoside treatment attenuated the Ti-induced inhibition on cell differentiation and apoptosis, increased alkaline phosphatase activity (ALP) and cell mineralization, and inhibited TNF-α, IL-1β, and IL-6 production and ROS generation. In BMSCs, curculigoside treatment suppressed the Ti-induced cell formation and suppressed the TNF-α, IL-1β, and IL-6 production and F-actin ring formation. In vivo, curculigoside attenuated Ti-induced bone loss and histological damage in murine calvaria. Curculigoside treatment also reversed the RANK/RANKL/OPG and NF-κB signaling pathways, by suppressing the RANKL and NF-κB expression, while activating the OPG expression. Our study demonstrated that curculigoside treatment was able to attenuate wear particle-induced periprosthetic osteolysis in in vivo and in vitro experiments, promoted osteoblastic MC3T3-E1 cell differentiation, and inhibited osteoclast BMSC formation. It suggests that curculigoside may be a potential pharmaceutical agent for wear particle-stimulated osteolysis therapy.

show abstract

A review of the New Zealand National Joint Registry to compare the outcomes of Coonrad-Morrey and Latitude total elbow arthroplasty

Cited by 19 publications

References 20 publications

Implant survival of total elbow arthroplasty: analysis of 514 cases from the Dutch Arthroplasty Registry

Implant survival of total elbow arthroplasty: analysis of 514 cases from the Dutch Arthroplasty Registry

Mid-term results of the Latitude primary total elbow arthroplasty

Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation

Contact Info

Product

Resources

About